Status:
COMPLETED
Comparison of Intramuscular Injection From Two Different Sites in Children
Lead Sponsor:
Sakarya University
Conditions:
Application Site Infection
Eligibility:
All Genders
4-6 years
Phase:
NA
Brief Summary
Administration of intramuscular injections (IM) is now common practice in pediatric clinical settings. For this reason, nurses should both update their clinical skills and provide evidence-based pract...
Detailed Description
Intramuscular injection (IMI) is widely used in the pediatric emergency department and is a cause of pain for children. The aim of this study is to compare the vastus lateralis (VL) and ventrogluteal ...
Eligibility Criteria
Inclusion
- Being in the age group of 4-6
- Ordering Prendol amp IM by the doctor,
- IM application in pediatric emergency,
- Absence of a disease that causes chronic pain,
- Absence of a neurodevelopmental disorder,
- Not taking analgesics in the last 6 hours,
- No history of fainting during the injection,
- Absence of mental retardation,
- Absence of scar tissue or muscle atrophy in the area to be injected,
- Being in the 10th to 90th percentile
- Families and children agree to participate in the research.
Exclusion
- \- being less than 4 years old,
- Over 6 years of age,
- Scar or muscle atrophy at the injection site,
- The child or parent has communication problems,
- The percentile is below 10 (cachectic) or over 90 (obese),
- Families and children do not agree to participate in the research.
Key Trial Info
Start Date :
March 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05279144
Start Date
March 25 2022
End Date
July 30 2022
Last Update
May 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sakarya Education and Training Hospital
Sakarya, Adapazarı, Turkey (Türkiye), 54050